Steven Seedhouse, Ph.D.

Steve Seedhouse joined Raymond James in 2018 as an analyst covering the biotechnology sector. He covered biotechnology as a senior associate at Citigroup, Stifel, and most recently BMO Capital Markets. Prior to that, he received a Ph.D. in molecular pharmacology from University at Buffalo while conducting drug discovery research at Roswell Park Cancer Institute in Buffalo, New York. Seedhouse also holds an MSc in medicinal chemistry from University at Buffalo and a B.S. in chemistry with honors from SUNY Brockport, where he was named male scholar athlete of the year. His research in cancer and drug discovery prior to joining Wall Street resulted in nine authored or co-authored publications.